JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2004) 183, 1-17    DOI: 10.1677/joe.1.05685
© 2004 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, P D
Right arrow Articles by Fraser, H M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, P D
Right arrow Articles by Fraser, H M

Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary

P D Taylor1,2, S G Hillier2 and H M Fraser1,2

1 Medical Research Council Human Reproductive Sciences Unit, 49 Little France Crescent, Edinburgh EH16 4SB, UK
2 University of Edinburgh Centre for Reproductive Biology, 49 Little France Crescent, Edinburgh EH16 4SB, UK

(Requests for offprints should be addressed to H M Fraser, Medical Research Council, Human Reproductive Sciences Unit, 49 Little France Crescent, Edinburgh EH16 4SB, UK; Email: h.fraser{at}hrsu.mrc.ac.uk)

Angiogenesis is required for normal follicular development but the role of gonadotrophins in the control of follicular angiogenesis remains to be elucidated. This study investigated the effects of treatment with GnRH antagonist in vivo on follicular development and angiogenesis in the marmoset. GnRH antagonist was administered on either follicular day 0 or day 5 of the 10-day follicular phase with ovaries collected on day 10. Ovaries from control marmosets were studied at day 5 (mid follicular phase) and day 10 (periovulatory period). Ovaries were fixed, serial sectioned and subjected to morphological analysis and immunocytochemistry to determine cell proliferation and follicular endothelial cell area and in situ hybridization to assess changes in expression of vascular endothelial growth factor (VEGF). Treatment with GnRH antagonist from day 0–10 resulted in an absence of dominant preovulatory follicles seen in controls. In the remaining tertiary follicles granulosa, theca and endothelial cell proliferation was reduced, resulting in a minor reduction in vascular density. However, VEGF mRNA expression was unaffected by treatment. Treatment from day 5–10 did not prevent development of ovulatory size follicles, but they were atretic and lacked VEGF mRNA. These results suggest that while VEGF expression in the preovulatory follicle is under gonadotrophic control it is not dependent on normal gonadotrophin secretion in tertiary follicles, indicating that there are other paracrine factors regulating VEGF expression in the developing ovarian follicle.




This article has been cited by other articles:


Home page
EndocrinologyHome page
W. C. Duncan, S. van den Driesche, and H. M. Fraser
Inhibition of Vascular Endothelial Growth Factor in the Primate Ovary Up-Regulates Hypoxia-Inducible Factor-1{alpha} in the Follicle and Corpus Luteum
Endocrinology, July 1, 2008; 149(7): 3313 - 3320.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Parborell, D. Abramovich, and M. Tesone
Intrabursal Administration of the Antiangiopoietin 1 Antibody Produces a Delay in Rat Follicular Development Associated with an Increase in Ovarian Apoptosis Mediated by Changes in the Expression of BCL2 Related Genes
Biol Reprod, March 1, 2008; 78(3): 506 - 513.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Thomas, H. Wilson, A. Silvestri, and H. M. Fraser
Thrombospondin-1 Expression Is Increased during Follicular Atresia in the Primate Ovary
Endocrinology, January 1, 2008; 149(1): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Thomas, E. E. Telfer, and H. M. Fraser
Expression of Anti-Mullerian Hormone Protein during Early Follicular Development in the Primate Ovary in Vivo Is Influenced by Suppression of Gonadotropin Secretion and Inhibition of Vascular Endothelial Growth Factor
Endocrinology, May 1, 2007; 148(5): 2273 - 2281.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. E. Roberts, L. K. Arbogast, C. I. Friedman, D. E. Cohn, P. T. Kaumaya, and D. R. Danforth
Neutralization of Endogenous Vascular Endothelial Growth Factor Depletes Primordial Follicles in the Mouse Ovary
Biol Reprod, February 1, 2007; 76(2): 218 - 223.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. M. Fraser, H. Wilson, J. S. Rudge, and S. J. Wiegand
Single Injections of Vascular Endothelial Growth Factor Trap Block Ovulation in the Macaque and Produce a Prolonged, Dose-Related Suppression of Ovarian Function
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1114 - 1122.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.